Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 2 of 2 entries
Sorted by: Best Match Show Resources per page
Correction to "Absorption, Distribution, Metabolism, and Excretion of the Oral Prostaglandin D2 Receptor 2 Antagonist Fevipiprant (QAW039) in Healthy Volunteers and In Vitro".

Drug metabolism and disposition: the biological fate of chemicals

[No authors listed]
PMID: 33593806
Drug Metab Dispos. 2021 Mar;49(3):287-288. doi: 10.1124/dmd.117.075358err.

No abstract available.

Cite
Correction to "Absorption, Distribution, Metabolism, and Excretion of the Oral Prostaglandin D2 Receptor 2 Antagonist Fevipiprant (QAW039) in Healthy Volunteers and In Vitro". Drug Metab Dispos. 2021;49(3):287-288doi: 10.1124/dmd.117.075358err.
(2021). Correction to "Absorption, Distribution, Metabolism, and Excretion of the Oral Prostaglandin D2 Receptor 2 Antagonist Fevipiprant (QAW039) in Healthy Volunteers and In Vitro". Drug metabolism and disposition: the biological fate of chemicals, 49(3), 287-288. https://doi.org/10.1124/dmd.117.075358err
"Correction to "Absorption, Distribution, Metabolism, and Excretion of the Oral Prostaglandin D2 Receptor 2 Antagonist Fevipiprant (QAW039) in Healthy Volunteers and In Vitro"." Drug metabolism and disposition: the biological fate of chemicals vol. 49,3 (2021): 287-288. doi: https://doi.org/10.1124/dmd.117.075358err
Correction to "Absorption, Distribution, Metabolism, and Excretion of the Oral Prostaglandin D2 Receptor 2 Antagonist Fevipiprant (QAW039) in Healthy Volunteers and In Vitro". Drug Metab Dispos. 2021 Mar;49(3):287-288. doi: 10.1124/dmd.117.075358err. PMID: 33593806.
Copy Download .nbib Format: NLM
Identification of DNA methylation-driven genes by integrative analysis of DNA methylation and transcriptome data in pancreatic adenocarcinoma.

Experimental and therapeutic medicine

Zhang W, Shang S, Yang Y, Lu P, Wang T, Cui X, Tang X.
PMID: 32256782
Exp Ther Med. 2020 Apr;19(4):2963-2972. doi: 10.3892/etm.2020.8554. Epub 2020 Feb 26.

Pancreatic adenocarcinoma (PAAD) is a painful and fatal disease that undoubtedly remains a health care priority and offers significant therapeutic challenges. The significance of epigenetic modifications, including DNA methylation in tumor development, has gained the attention of researchers. Identifying...

Cite
Zhang W, Shang S, Yang Y, et al. Identification of DNA methylation-driven genes by integrative analysis of DNA methylation and transcriptome data in pancreatic adenocarcinoma. Exp Ther Med. 2020;19(4):2963-2972doi: 10.3892/etm.2020.8554.
Zhang, W., Shang, S., Yang, Y., Lu, P., Wang, T., Cui, X., & Tang, X. (2020). Identification of DNA methylation-driven genes by integrative analysis of DNA methylation and transcriptome data in pancreatic adenocarcinoma. Experimental and therapeutic medicine, 19(4), 2963-2972. https://doi.org/10.3892/etm.2020.8554
Zhang, Wei, et al. "Identification of DNA methylation-driven genes by integrative analysis of DNA methylation and transcriptome data in pancreatic adenocarcinoma." Experimental and therapeutic medicine vol. 19,4 (2020): 2963-2972. doi: https://doi.org/10.3892/etm.2020.8554
Zhang W, Shang S, Yang Y, Lu P, Wang T, Cui X, Tang X. Identification of DNA methylation-driven genes by integrative analysis of DNA methylation and transcriptome data in pancreatic adenocarcinoma. Exp Ther Med. 2020 Apr;19(4):2963-2972. doi: 10.3892/etm.2020.8554. Epub 2020 Feb 26. PMID: 32256782; PMCID: PMC7086284.
Copy Download .nbib Format: NLM
Showing 1 to 2 of 2 entries